TrialCancer science2020

Peptide vaccine as an adjuvant therapy for glypican-3-positive hepatocellular carcinoma induces peptide-specific CTLs and improves long prognosis.

Masatake Taniguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.